APA (7th ed.) Citation

Berges, J., Gräber, S. Y., Hämmerling, S. H., Yu, Y., Krümpelmann, A., Stahl, M., . . . Sommerburg, O. (2023). Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years. Frontiers in pharmacology, 14, . https://doi.org/10.3389/fphar.2023.1188051

Chicago Style (17th ed.) Citation

Berges, Julian, et al. "Effects of Lumacaftor—ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in F508del Homozygous Patients with Cystic Fibrosis Aged 2-11 Years." Frontiers in Pharmacology 14 (2023). https://doi.org/10.3389/fphar.2023.1188051.

MLA (9th ed.) Citation

Berges, Julian, et al. "Effects of Lumacaftor—ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in F508del Homozygous Patients with Cystic Fibrosis Aged 2-11 Years." Frontiers in Pharmacology, vol. 14, 2023, https://doi.org/10.3389/fphar.2023.1188051.